Publications
1. Eberhardt CD., Kissick HT., Patel MR., Cardenas MA., Prokhnevska N., Obeng RC., Nasti TH., Griffith CC., Im SJ., Wang X., Shin DM., Carrington M., Chen ZG., Sidney J., Sette A., Saba NF., Wieland A.*, Ahmed R. (2021) Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer. Nature. 597(7875):279-284 *co-senior and co-corresponding author
2. Wieland A.*, Patel MR., Cardenas MA., Eberhardt CS., Hudson WH., Obeng RC., Griffith CC., Wang X., Chen ZG., Kissick HT., Saba NF., Ahmed R. (2021) Defining HPV-specific B cell responses in head and neck cancer patients. Nature. 597(7875):274-278 *co-corresponding author
3. Wieland A., Ahmed R. Immunological lessons from CD28 deficiency in humans. Cell. 184(14):3595-3597
4. Chang YM., Wieland A., Li Z-R., Im SJ., McGuire DJ., Kissick HT., Antia R., Ahmed R. (2020) T cell receptor diversity and lineage relationship between virus-specific CD8 T cell subsets during chronic
lymphocytic choriomeningitis virus infection. JVI 94:e00935-20
5. Eberhardt CS., Wieland A., Nasti TH., Grifoni A., Wilson E., Schmid DS., Pulendran B., Sette A., Waller EK., Rouphael N., Ahmed R. (2020) Persistence of varicella-zoster virus-specific plasma cells in adult human bone marrow following childhood vaccination. JVI. 94(13)
6. Hudson WH., Gensheimer J., Hashimoto M., Wieland A., Valanparambil RM., Li P., Lin JX., Konieczny BT., Im SJ., Freeman GJ., Leonard WJ., Kissick HT., Ahmed R. (2019) Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1+ stem-like CD8+ T cells during chronic infection. Immunity. 51(6):1043-1058
7. Wieland A.*, Kamphorst AO., Valanparambil RM., Han JH., Xu X., Choudhury BP., Ahmed R. (2018) Enhancing FcR-mediated antibody effector functions during persistent viral infection. Sci Immunol. 3(27). pii: eaao3125 *co-corresponding author
8. Wieland A., Kamphorst AO., Adsay NV., Masor JJ., Sarmiento J., Nasti TH., Darko S., Doueck DC., Xue Y., Curran WJ., Lawson DH., Ahmed R. (2018) T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patient. Cancer Immunol Immunother. 67(11):1767-1776
9. Kamphorst AO., Wieland A., Nasti T., Yang S., Zhang R., Barber DL., Konieczny BT., Daugherty CZ., Koenig L., Yu K., Sica GL., Sharpe AH., Freeman GJ., Blazar BR., Turka LA., Owonikoko TK., Pillai R., Ramalingam SS., Araki K., Ahmed R. (2017) Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent. Science. 355(6332):1423-1427
10. Wieland A., Shashidharamurthy R., Kamphorst AO., Han JH., Aubert RA., Choudhoury BP., Stowell SR., Lee J., Punkosdy GA., Shlomchik MJ., Selvaraj P., Ahmed R. (2015) Antibody effector functions mediated by Fc-receptors are compromised during persistent viral infection. Immunity. 42(2):367-378